Based in Highland's Menlo Park office, Bijan focuses on investments in medical device, healthcare services and healthcare information technology companies. Bijan represents Highland on the board of BÂRRX Medical, Hyperion Therapeutics, OpGen and Predictive Biosciences, and is or has been actively involved in Highland's investments in BAROnova and Conor Medsystems (IPO; acquired by Johnson & Johnson).

Read Bijan’s blog: musings on venture capital, healthcare, medical devices, technology, gadgets, and other stuff of interest.

Background
Prior to joining Highland, Bijan spent several years in marketing and strategic planning at Medtronic Vascular, a world leader in medical technology. Before Medtronic, Bijan held a variety of management roles HealthCentral, a venture-backed healthcare information technology and commerce start-up that went public.

During his medical training, Bijan conducted research in minimally invasive heart valves and left ventricular assist devices, and his work was published in several peer-reviewed scientific journals. He also served as a researcher at the National Heart, Lung, and Blood Institute where he investigated coronary artery disease.

Bijan has also served as a member of the Kauffman Fellows program.

Education
Princeton University, A.B., Molecular Biology
Columbia University, M.S., Health Policy
Columbia University, M.D., Medicine
Harvard Business School, M.B.A.

Follow Bijan on Twitter: www.twitter.com/bijans